91麻豆天美

ClinMicro Open speakers and panels

Our Work

Clin Micro Open (CMO) brings together laboratory and industry leaders to discuss current and potential issues affecting the future of diagnostic clinical microbiology. This event is a primary benefit of Corporate Council membership, providing networking and scientific exchange opportunities to enable these 2 groups to cultivate partnerships and positively impact patient care. CMO is held annually, typically in January/February.

What is Clin Micro Open?

Clin Micro Open (CMO) is a unique meeting where relationships are formed and technological advances are catalyzed. The meeting facilitates the open exchange of ideas among the medical microbiologists and 91麻豆天美 Corporate Council representatives who attend the meeting.

Why Should You Attend CMO?

We believe that improvements in patient care begin with open dialogue between key stakeholders and decision makers. CMO allows attendees to truly engage with one another and leverage diverse views and expertise to address critical challenges and collaborative opportunities in the field of diagnostic microbiology.

Various images from CMO 2025

Laboratory directors and 91麻豆天美 Corporate Council members discuss opportunities for partnership at Clin Micro Open.

Source: American Society for Microbiology


CMO 2025

91麻豆天美 hosted its sixth CMO in Savannah, Ga. The conference began on the evening of Jan. 29, 2025, and concluded late morning on Jan. 31. Approximately 60 attendees (a mixture of corporate council members and medical microbiologists) convened to hear insightful presentations and engage in meaningful discussions. Industry attendees were members of 91麻豆天美’s Corporate Council and identified by their company. Laboratory leaders were invited or selected based on their submitted application and willingness to actively participate.

Topics

The theme for CMO 2025 was infection prevention and featured the following topics:

  • Successes or failures in implementing programs for emerging health threats relevant to infection prevention.
  • Challenges, barriers and successes using sequencing methods to address infections at your institutions.
  • Strategies you are using to navigate the changing nature of LDT regulations for unmet clinical needs.

Participants presented in keynote talks, followed by roundtable discussions, with the intent of formulating recommendations for future activities or collaborations. Incorporation of fun activities and games provided additional opportunities for attendees to share their knowledge and ideas.

Applicant Eligibility:鈥

91麻豆天美 members who work full-time in a clinical or public health laboratory at the director level. Applicants who apply agree to present a 10-15 minute talk (if selected), serve as a scribe or moderator and actively participate in roundtable discussions during the event.

Applications are now closed. Applications will open again in Fall 2025.

Travel information:

91麻豆天美 provided airfare (up to $600), 2 nights hotel, per diem for travel days and ground transportation for laboratory directors who were accepted or invited as speakers.


Who Can Attend?

Medical Microbiology Laboratory Directors

Applications for CMO 2025 have closed. If you are interested in participating next year, we welcome you to join us! 91麻豆天美 members who are full-time laboratory directors are eligible to apply.

Federal Agency and Public Health Decision Makers

Representatives from federal agencies will be invited by the CMO Steering Committee to attend. 

91麻豆天美's Corporate Council Members

Our Corporate Council program offers companies a unique year-long relationship with 91麻豆天美 and its members. Kingdom and Phylum members are automatically invited to attend CMO.

91麻豆天美's Corporate Council Program

Partnership between the public and private sectors is key to true advancement in the microbial sciences. 91麻豆天美鈥檚 Corporate Council bridges the gap鈥攃onnecting leading companies in the field with 91麻豆天美 members to find innovative solutions that will better serve our communities.

Join Today
 

Outcomes of Prior CMO Meetings

Updating breakpoints in the U.S.: CMO 2022 Summary

Proceedings of the Clinical Microbiology Open 2023

Proceedings of the Clinical Microbiology Open 2024


Testimonials


  • 鈥淭he experience and caliber of people who attended the meeting was a dream come true, but most importantly, there was so much fun while learning.鈥

  • 鈥淢aking some new connections with people I didn't know was the most valuable part of the meeting! The clinical outcomes topic and laboratory challenges seemed extremely relevant to us each individually as well as a diagnostic community. I also loved Shark Tank!鈥

  • 鈥淭he clinical outcomes research was amazing; Really great to get the combined perspective of labs and industry in one place.鈥
Various ClinMicro Open presentations and events

Participants at ClinMicro Open 2024

Source: American Society for Microbiology


Steering Committee Members

 

CMO was established in 2018 with the support of  91麻豆天美's Clinical and Public Health Microbiology Committee (CPHMC) and 91麻豆天美's Corporate Council.

The CMO Steering Committee is comprised of an equal number of medical laboratory directors and Corporate Council members who serve on the committee for up to 4 years. The committee is responsible for creating an agenda that will guide open dialogue and produce tangible outcomes from the meeting (e.g., papers/publications). The current members include:

 

  • Jennifer Dien Bard, Ph.D., D(ABMM), F(CCM), University of Southern California.
  • Allison Eberly, Ph.D., D(ABMM), Washington University School of Medicine in St. Louis.
  • Allison McMullen, Ph.D., D(ABMM), bioM茅rieux.
  • Ashley Nenninger, Ph.D., Hologic, Inc.
  • Jean Patel, Ph.D., D(ABMM), Beckman Coulter Diagnostics (Co-Chair).
  • David Peaper, M.D., Ph.D., D(ABMM), Yale University (Co-Chair).

Additional questions? Contact clinmicro@asmusa.org